Clinical
RSSArticles
-
Laborists: How Will It Affect Care?
A recent study has shown a decrease in rates of induction, cesarean section, and preterm birth in hospitals after instituting a laborist model, compared with matched-control hospitals using the traditional model.
-
Who Needs an Endometrial Biopsy?
In this retrospective cohort study of premenopausal women with abnormal uterine bleeding, obesity, as opposed to age, was the most significant predictor of complex hyperplasia or cancer on endometrial biopsy.
-
Did You Remember to Take Your Hormone Replacement? The Treatment May Not Help
Women randomized to receive postmenopausal oral estradiol therapy did not show improved memory, executive function, or global cognition, and timing of initiation of hormonal treatment did not affect the outcome.
-
Identifying Risk for Macrovascular Events in Diabetes Patients
The simple clinical maneuver of peripheral pulse palpation can help clinicians identify a subgroup of type 2 diabetes patients who are at measurably increased risk.
-
Atrial Fibrillation Still a Mortal Disorder
Researchers propose paying greater attention to prevention, identification, and management of heart failure.
-
Prophylaxis of Genital Herpes Recurrences with Antivirals
In the absence of head-to-head clinical trials, no substantial differences in efficacy or tolerability among the three potential treatments has been demonstrated.
-
An Action Plan for Eczema
Action plans for eczema are a fairly new concept.
-
Atopic Dermatitis Associated with Smoking
Of particular concern, smoking in the home was associated with atopic dermatitis in passively exposed children.
-
Orthostatic Changes in BP Among Hypertensives
Because patients may not always be forthcoming about symptoms referable to orthostatic hypotension, more routine measurement of orthostatic blood pressure changes in hypertensive patients may help identify those at risk.
-
FDA Actions
In this section: FDA removes black box warning from popular smoking cessation drug, approves treatment for young eczema patients, greenlights drug for spinal muscular atrophy, and links a drug to higher bladder cancer risk.